Skip to Main Content

Paper Details

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial.
Clin Appl Thromb Hemost
1
2022
Aspirin, Intermittent Claudication, Peripheral Arterial Disease, Rivaroxaban, aspirin, intermittent claudication, patients, peripheral arterial disease, rivaroxaban
Author NameAffiliation
Sonia S Anand0McMaster University
Renato D Lopes169103Duke Clinical Research Institute, Duke University
  • 1 - 2

Datasets

Release 1.2